journal article·2020-02-26

Gd-/CuS-Loaded Functional Nanogels for MR/PA Imaging-Guided Tumor-Targeted Photothermal Therapy

Changchang Zhang, Wenjie Sun, Yue Wang, Fang Xu, Jiao Qu, Jindong Xia, Mingwu Shen, Xiangyang Shi

Publisher page

Abstract

The second near-infrared (NIR-II, 1000–1700 nm) light-based diagnosis and therapy have received extensive attention for neoplastic disease treatments because of the fact that light in the NIR-II window possesses less photon scattering along with deeper tissue penetration than that in the NIR-I (700–950 nm) window. Herein, we present a Gd- and copper sulfide (CuS)-integrated nanogel (NG) platform for magnetic resonance (MR)/photoacoustic (PA) imaging-guided tumor-targeted photothermal therapy (PTT). In our approach, we prepared cross-linked polyethylenimine (PEI) NGs via an inverse emulsion method, modified the PEI NGs with Gd chelates, targeting ligand folic acid (FA) through a polyethylene glycol (PEG) spacer and 1,3-propanesultone, and finally loaded CuS nanoparticles (NPs) within the functional NGs. The as-synthesized Gd/CuS@PEI-FA-PS NGs with a mean size of 85 nm exhibit a good water dispersibility and protein resistance property, admirable r1 relaxivity (11.66 mM–1 s–1), excellent NIR-II absorption feature, high photothermal conversion efficiency (26.7%), and FA-mediated targeting specificity to cancer cells overexpressing FA receptor (FAR). With these properties along with the good cytocompatibility, the developed Gd/CuS@PEI-FA-PS NGs enable MR/PA dual-mode imaging-guided targeted PTT of FAR-overexpressing tumors under the irradiation of an NIR-II (1064 nm) laser. The designed Gd/CuS@PEI-FA-PS NGs may be used as a promising theranostic agent for MR/PA dual-mode imaging-guided PTT of other FAR-expressing tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory for Modification of Chemical Fiber and Polymer Materials, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, People’s Republic of China

Department of Radiology, Shanghai Songjiang District Central Hospital, Shanghai 201600, People’s Republic of China

CQM-Centro de Quimica da Madeira, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal

Funding

Ministry of Education of the People's Republic of China · Chinesisch-Deutsche Zentrum f?r Wissenschaftsf?rderung · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.3389/fchem.2019.0016710.3389/fchem.2019.00167 ↗
2. 10.1021/acsnano.7b0687010.1021/acsnano.7b06870 ↗
3. 10.1097/01.gco.0000192996.20040.2410.1097/01.gco.0000192996.20040.24 ↗
4. 10.1038/nnano.2015.34310.1038/nnano.2015.343 ↗
5. 10.1158/1078-0432.ccr-16-087010.1158/1078-0432.ccr-16-0870 ↗
6. 10.1039/c4nr00708e10.1039/c4nr00708e ↗
7. 10.1039/c4cs00011k10.1039/c4cs00011k ↗
8. 10.7150/thno.1498810.7150/thno.14988 ↗
9. 10.1039/c4cs00394b10.1039/c4cs00394b ↗
10. 10.1021/acs.nanolett.8b0461810.1021/acs.nanolett.8b04618 ↗
11. 10.1039/c8cs00618k10.1039/c8cs00618k ↗
12. 10.1088/0022-3727/38/15/00410.1088/0022-3727/38/15/004 ↗
13. American National Institute · 2007
14. 10.1200/jco.2006.06.594610.1200/jco.2006.06.5946 ↗
15. 10.1038/s41467-017-00741-y10.1038/s41467-017-00741-y ↗
16. 10.1038/nature0691710.1038/nature06917 ↗
17. 10.1098/rsfs.2011.002810.1098/rsfs.2011.0028 ↗
18. 10.1126/science.121621010.1126/science.1216210 ↗
19. 10.2528/pier1403230310.2528/pier14032303 ↗
20. 10.1039/c7nr04241h10.1039/c7nr04241h ↗
21. 10.1021/acs.biomac.8b0018410.1021/acs.biomac.8b00184 ↗
22. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
23. 10.7150/thno.2169410.7150/thno.21694 ↗
24. 10.7150/thno.1175410.7150/thno.11754 ↗
25. 10.1021/nn506130t10.1021/nn506130t ↗
26. 10.1002/adfm.20150200310.1002/adfm.201502003 ↗
27. 10.1002/anie.20181008210.1002/anie.201810082 ↗
28. 10.1016/j.cej.2019.12392510.1016/j.cej.2019.123925 ↗
29. 10.1039/c8cc06736h10.1039/c8cc06736h ↗
30. 10.2147/ijn.s14631510.2147/ijn.s146315 ↗
31. 10.1021/acsnano.5b0752110.1021/acsnano.5b07521 ↗
32. 10.1002/mabi.20180041610.1002/mabi.201800416 ↗
33. 10.1016/j.colsurfb.2016.01.01910.1016/j.colsurfb.2016.01.019 ↗
34. 10.1016/j.msec.2017.03.28510.1016/j.msec.2017.03.285 ↗
35. 10.1002/anie.20170162010.1002/anie.201701620 ↗
36. 10.1021/acsami.8b2167910.1021/acsami.8b21679 ↗
37. 10.1021/ja106855m10.1021/ja106855m ↗
38. 10.1002/adma.20110129510.1002/adma.201101295 ↗
39. 10.1039/c4ta03199g10.1039/c4ta03199g ↗
40. 10.1039/c7nr03940a10.1039/c7nr03940a ↗
41. 10.1021/acsami.6b1421910.1021/acsami.6b14219 ↗
42. 10.1039/c8tb01044g10.1039/c8tb01044g ↗
43. 10.1021/cr900232t10.1021/cr900232t ↗
44. 10.1002/ejic.20110130510.1002/ejic.201101305 ↗
45. 10.1039/c5dt00198f10.1039/c5dt00198f ↗
46. 10.1039/c5ra01215e10.1039/c5ra01215e ↗
47. 10.3390/pharmaceutics1003016210.3390/pharmaceutics10030162 ↗
48. 10.1039/c7sc04004k10.1039/c7sc04004k ↗
49. 10.1053/j.tvir.2013.08.00210.1053/j.tvir.2013.08.002 ↗